Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective

You'll see fewer payers requiring a trial of immediate-release oxybutynin for overactive bladder before approving an alternative.

Oxybutynin IR has been the least expensive...but the cost of some of the other antimuscarinics are coming down as more of them go generic.

For mild symptoms of overactive bladder, stick with nondrug measures first...limiting caffeine, bladder training, etc. Explain these strategies can work as well as meds...if patients are diligent.